Cargando…

It Takes Two: Endothelial-Perivascular Cell Cross-Talk in Vascular Development and Disease

The formation of new blood vessels is a crucial step in the development of any new tissue both during embryogenesis and in vitro models as without sufficient perfusion the tissue will be unable to grow beyond the size where nutrition and oxygenation can be managed by diffusion alone. Endothelial cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Sweeney, Mark, Foldes, Gabor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218412/
https://www.ncbi.nlm.nih.gov/pubmed/30425990
http://dx.doi.org/10.3389/fcvm.2018.00154
_version_ 1783368443731378176
author Sweeney, Mark
Foldes, Gabor
author_facet Sweeney, Mark
Foldes, Gabor
author_sort Sweeney, Mark
collection PubMed
description The formation of new blood vessels is a crucial step in the development of any new tissue both during embryogenesis and in vitro models as without sufficient perfusion the tissue will be unable to grow beyond the size where nutrition and oxygenation can be managed by diffusion alone. Endothelial cells are the primary building block of blood vessels and are capable of forming tube like structures independently however they are unable to independently form functional vasculature which is capable of conducting blood flow. This requires support from other structures including supporting perivascular cells and the extracellular matrix. The crosstalk between endothelial cells and perivascular cells is vital in regulating vasculogenesis and angiogenesis and the consequences when this is disrupted can be seen in a variety of congenital and acquired disease states. This review details the mechanisms of vasculogenesis in vivo during embryogenesis and compares this to currently employed in vitro techniques. It also highlights clinical consequences of defects in the endothelial cell—pericyte cross-talk and highlights therapies which are being developed to target this pathway. Improving the understanding of the intricacies of endothelial—pericyte signaling will inform pathophysiology of multiple vascular diseases and allow the development of effective in vitro models to guide drug development and assist with approaches in tissue engineering to develop functional vasculature for regenerative medicine applications.
format Online
Article
Text
id pubmed-6218412
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-62184122018-11-13 It Takes Two: Endothelial-Perivascular Cell Cross-Talk in Vascular Development and Disease Sweeney, Mark Foldes, Gabor Front Cardiovasc Med Cardiovascular Medicine The formation of new blood vessels is a crucial step in the development of any new tissue both during embryogenesis and in vitro models as without sufficient perfusion the tissue will be unable to grow beyond the size where nutrition and oxygenation can be managed by diffusion alone. Endothelial cells are the primary building block of blood vessels and are capable of forming tube like structures independently however they are unable to independently form functional vasculature which is capable of conducting blood flow. This requires support from other structures including supporting perivascular cells and the extracellular matrix. The crosstalk between endothelial cells and perivascular cells is vital in regulating vasculogenesis and angiogenesis and the consequences when this is disrupted can be seen in a variety of congenital and acquired disease states. This review details the mechanisms of vasculogenesis in vivo during embryogenesis and compares this to currently employed in vitro techniques. It also highlights clinical consequences of defects in the endothelial cell—pericyte cross-talk and highlights therapies which are being developed to target this pathway. Improving the understanding of the intricacies of endothelial—pericyte signaling will inform pathophysiology of multiple vascular diseases and allow the development of effective in vitro models to guide drug development and assist with approaches in tissue engineering to develop functional vasculature for regenerative medicine applications. Frontiers Media S.A. 2018-10-30 /pmc/articles/PMC6218412/ /pubmed/30425990 http://dx.doi.org/10.3389/fcvm.2018.00154 Text en Copyright © 2018 Sweeney and Foldes. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Sweeney, Mark
Foldes, Gabor
It Takes Two: Endothelial-Perivascular Cell Cross-Talk in Vascular Development and Disease
title It Takes Two: Endothelial-Perivascular Cell Cross-Talk in Vascular Development and Disease
title_full It Takes Two: Endothelial-Perivascular Cell Cross-Talk in Vascular Development and Disease
title_fullStr It Takes Two: Endothelial-Perivascular Cell Cross-Talk in Vascular Development and Disease
title_full_unstemmed It Takes Two: Endothelial-Perivascular Cell Cross-Talk in Vascular Development and Disease
title_short It Takes Two: Endothelial-Perivascular Cell Cross-Talk in Vascular Development and Disease
title_sort it takes two: endothelial-perivascular cell cross-talk in vascular development and disease
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218412/
https://www.ncbi.nlm.nih.gov/pubmed/30425990
http://dx.doi.org/10.3389/fcvm.2018.00154
work_keys_str_mv AT sweeneymark ittakestwoendothelialperivascularcellcrosstalkinvasculardevelopmentanddisease
AT foldesgabor ittakestwoendothelialperivascularcellcrosstalkinvasculardevelopmentanddisease